Researchers from Peter Mac have discovered an innovative way to dampen severe inflammation, uncovering a potential new therapeutic approach for inflammatory and autoimmune conditions such as arthritis, psoriasis and liver disease, as well as some cancers.
Due to COVID-19, Peter MacCallum Cancer Centre, the Royal Women’s Hospital, the Royal Melbourne Hospital and The Royal Children’s Hospital are postponing the go-live of the Parkville Electronic Medical Record (EMR).
Peter Mac’s Executive Director Cancer Research, Prof Ricky Johnstone, has announced the appointment of three new Associate Directors covering clinical, translational and health services and implementation science.
Results from a Peter Mac-led randomised controlled trial – the proPSMA Study - find that a new molecular imaging technique is more accurate than conventional medical imaging and recommends the scans be introduced into routine clinical practice.
Infectious diseases clinician, Dr Olivia Smibert, is the first Peter Mac student ever awarded the Gustav Nossal Scholarship – NHMRC’s top PhD scholarship – to undertake studies into whether the gut microbiome can influence transplant success.
The Peter MacCallum Cancer Centre acknowledges the traditional
owners of the land on which our five sites are located throughout Victoria.
We recognise their strength and resilience and pay our respects
to their Elders past and present.